These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74. Contraception for Adolescents: Focusing on Long-Acting Reversible Contraceptives (LARC) to Improve Reproductive Health Outcomes. Kaneshiro B; Salcedo J Curr Obstet Gynecol Rep; 2015 Mar; 4(1):53-60. PubMed ID: 27635305 [TBL] [Abstract][Full Text] [Related]
75. Increasing Use of Long-Acting Reversible Contraception to Decrease Unplanned Pregnancy. Lotke PS Obstet Gynecol Clin North Am; 2015 Dec; 42(4):557-67. PubMed ID: 26598299 [TBL] [Abstract][Full Text] [Related]
76. Use of Long-Acting Reversible Contraception (LARC) and the Depo-Provera Shot in Adolescents. Itriyeva K Curr Probl Pediatr Adolesc Health Care; 2018 Dec; 48(12):321-332. PubMed ID: 30466840 [TBL] [Abstract][Full Text] [Related]
78. Myths and misconceptions about long-acting reversible contraception (LARC). Russo JA; Miller E; Gold MA J Adolesc Health; 2013 Apr; 52(4 Suppl):S14-21. PubMed ID: 23535052 [TBL] [Abstract][Full Text] [Related]
79. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline. Mavranezouli I; Hum Reprod; 2008 Jun; 23(6):1338-45. PubMed ID: 18372257 [TBL] [Abstract][Full Text] [Related]
80. Contraceptive choices of adolescents before and after the voluntary termination of pregnancy. Kokanalı D; Kuntay Kokanalı M; Ayhan S; Cengaver N; Özakşit G; Engin-Üstün Y J Obstet Gynaecol; 2019 Aug; 39(6):822-826. PubMed ID: 31010335 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]